Ribosomal protein L34 pseudogene 31 (RPL34P31)

RPL34P31 is classified as a **pseudogene** of the gene encoding ribosomal protein L34 and does not produce a functional protein[1][4]. Pseudogenes such as RPL34P31 are non-coding segments of DNA resembling coding genes but generally lack the ability to encode a functional product due to mutations or truncations. There is no evidence or annotation indicating RPL34P31 acts as a therapeutic target, nor does it have a direct disease association, interact with known drugs, or serve as a biomarker[1]. While ribosomal protein L34 (RPL34) is itself a functional ribosomal protein involved in the assembly and function of ribosomes in protein synthesis[7], RPL34P31 is one of many processed pseudogenes derived from RPL34 and dispersed throughout the genome[1][7]. Pseudogenes in general may participate in certain regulatory or evolutionary processes, but RPL34P31 has no documented role in disease, signaling pathways, or therapy. Curation notes: This entity is *not a therapeutic target* (not a receptor, enzyme, transporter, etc.). There are *no known drugs* or disease associations. Pseudogenes like RPL34P31 are frequently annotated in genomic databases but are not considered functionally relevant as drug targets or biomarkers[1][4]. If you are seeking the functional protein, the correct entity would be "60S ribosomal protein L34" (RPL34)[7].

Other names

RPL34P31RPL34_16_1528